Literature DB >> 27942588

Tumor-infiltrating lymphocytes are dynamically desensitized to antigen but are maintained by homeostatic cytokine.

Bijan Boldajipour1, Amanda Nelson1, Matthew F Krummel1,2.   

Abstract

T cells that enter tumors are largely tolerized, but how that process is choreographed and how the ensuing "dysfunctional" tumor-infiltrating lymphocytes (TILs) are maintained are poorly understood and are difficult to assess in spontaneous disease. We exploited an autochthonous model of breast cancer for high-resolution imaging of the early and later stages of tumor residence to understand the relationships between cellular behaviors and cellular phenotypes. "Dysfunctional" differentiation began within the first days of tumor residence with an initial phase in which T cells arrest, largely on tumor-associated macrophages. Within 10 days, cellular motility increased and resembled a random walk, suggesting a relative absence of TCR signaling. We then studied the concurrent and apparently contradictory phenomenon that many of these cells express molecular markers of activation and were visualized undergoing active cell division. We found that whereas proliferation did not require ongoing TCR/ZAP70 signaling, instead this is driven in part by intratumoral IL-15 cytokine. Thus, TILs undergo sequential reprogramming by the tumor microenvironment and are actively retained, even while being antigen insensitive. We conclude that this program effectively fills the niche with ineffective yet cytokine-dependent TILs, and we propose that these might compete with new clones, when they arise.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27942588      PMCID: PMC5135268          DOI: 10.1172/jci.insight.89289

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  56 in total

1.  Two-photon imaging of lymphocyte motility and antigen response in intact lymph node.

Authors:  Mark J Miller; Sindy H Wei; Ian Parker; Michael D Cahalan
Journal:  Science       Date:  2002-05-16       Impact factor: 47.728

2.  T cell and APC dynamics in situ control the outcome of vaccination.

Authors:  Kamal M Khanna; David A Blair; Anthony T Vella; Stephen J McSorley; Sandip K Datta; Leo Lefrançois
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

3.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases.

Authors:  Thorsten R Mempel; Sarah E Henrickson; Ulrich H Von Andrian
Journal:  Nature       Date:  2004-01-08       Impact factor: 49.962

4.  Dynamic in situ cytometry uncovers T cell receptor signaling during immunological synapses and kinapses in vivo.

Authors:  Hélène D Moreau; Fabrice Lemaître; Emmanuel Terriac; Georges Azar; Matthieu Piel; Ana-Maria Lennon-Dumenil; Philippe Bousso
Journal:  Immunity       Date:  2012-06-07       Impact factor: 31.745

5.  Subcellular dynamics of T cell immunological synapses and kinapses in lymph nodes.

Authors:  Georges A Azar; Fabrice Lemaître; Ellen A Robey; Philippe Bousso
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-04       Impact factor: 11.205

6.  Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models.

Authors:  Peter R Rhode; Jack O Egan; Wenxin Xu; Hao Hong; Gabriela M Webb; Xiaoyue Chen; Bai Liu; Xiaoyun Zhu; Jinghai Wen; Lijing You; Lin Kong; Ana C Edwards; Kaiping Han; Sixiang Shi; Sarah Alter; Jonah B Sacha; Emily K Jeng; Weibo Cai; Hing C Wong
Journal:  Cancer Immunol Res       Date:  2015-10-28       Impact factor: 11.151

7.  Chimeric antigen receptor T cells for sustained remissions in leukemia.

Authors:  Shannon L Maude; Noelle Frey; Pamela A Shaw; Richard Aplenc; David M Barrett; Nancy J Bunin; Anne Chew; Vanessa E Gonzalez; Zhaohui Zheng; Simon F Lacey; Yolanda D Mahnke; Jan J Melenhorst; Susan R Rheingold; Angela Shen; David T Teachey; Bruce L Levine; Carl H June; David L Porter; Stephan A Grupp
Journal:  N Engl J Med       Date:  2014-10-16       Impact factor: 91.245

Review 8.  T cell migration, search strategies and mechanisms.

Authors:  Matthew F Krummel; Frederic Bartumeus; Audrey Gérard
Journal:  Nat Rev Immunol       Date:  2016-02-08       Impact factor: 53.106

9.  The transcription factor NFAT exhibits signal memory during serial T cell interactions with antigen-presenting cells.

Authors:  Francesco Marangoni; Thomas T Murooka; Teresa Manzo; Edward Y Kim; Esteban Carrizosa; Natalie M Elpek; Thorsten R Mempel
Journal:  Immunity       Date:  2013-01-11       Impact factor: 31.745

Review 10.  Homeostasis of naive and memory T cells.

Authors:  Charles D Surh; Jonathan Sprent
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

View more
  15 in total

1.  STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth.

Authors:  Chunyan Zhang; Chanyu Yue; Andreas Herrmann; Jieun Song; Colt Egelston; Tianyi Wang; Zhifang Zhang; Wenzhao Li; Heehyoung Lee; Maryam Aftabizadeh; Yi Jia Li; Peter P Lee; Stephen Forman; George Somlo; Peiguo Chu; Laura Kruper; Joanne Mortimer; Dave S B Hoon; Wendong Huang; Saul Priceman; Hua Yu
Journal:  Cell Metab       Date:  2019-11-21       Impact factor: 27.287

Review 2.  Tissue-resident lymphocytes: from adaptive to innate immunity.

Authors:  Haoyu Sun; Cheng Sun; Weihua Xiao; Rui Sun
Journal:  Cell Mol Immunol       Date:  2019-01-11       Impact factor: 11.530

3.  Imbalance of immunological synapse-kinapse states reflects tumor escape to immunity in glioblastoma.

Authors:  Laura R Díaz; Elena Saavedra-López; Leire Romarate; Izaskun Mitxitorena; Paola V Casanova; George P Cribaro; José M Gallego; Ana Pérez-Vallés; Jerónimo Forteza-Vila; Clara Alfaro-Cervello; José M García-Verdugo; Carlos Barcia; Carlos Barcia
Journal:  JCI Insight       Date:  2018-09-20

4.  Intratumoral CD8+ T-cell Apoptosis Is a Major Component of T-cell Dysfunction and Impedes Antitumor Immunity.

Authors:  Brendan L Horton; Jason B Williams; Alexandra Cabanov; Stefani Spranger; Thomas F Gajewski
Journal:  Cancer Immunol Res       Date:  2017-11-02       Impact factor: 11.151

5.  Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation.

Authors:  Niwa Ali; Bahar Zirak; Robert Sanchez Rodriguez; Mariela L Pauli; Hong-An Truong; Kevin Lai; Richard Ahn; Kaitlin Corbin; Margaret M Lowe; Tiffany C Scharschmidt; Keyon Taravati; Madeleine R Tan; Roberto R Ricardo-Gonzalez; Audrey Nosbaum; Marta Bertolini; Wilson Liao; Frank O Nestle; Ralf Paus; George Cotsarelis; Abul K Abbas; Michael D Rosenblum
Journal:  Cell       Date:  2017-05-25       Impact factor: 41.582

6.  SET/PP2A signaling regulates macrophage positioning in hypoxic tumor regions by amplifying chemotactic responses.

Authors:  Shaolong Zhang; Jingping Zhou; Pengzhao Shang; Guomeng Zhao; Anlei Wang; Jinlei Mao; Yuhang Tao; Ziyi Chen; Xuehao Wang; Changying Guo
Journal:  Exp Mol Med       Date:  2022-10-12       Impact factor: 12.153

7.  Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer.

Authors:  Kelly Kersten; Kenneth H Hu; Alexis J Combes; Bushra Samad; Tory Harwin; Arja Ray; Arjun Arkal Rao; En Cai; Kyle Marchuk; Jordan Artichoker; Tristan Courau; Quanming Shi; Julia Belk; Ansuman T Satpathy; Matthew F Krummel
Journal:  Cancer Cell       Date:  2022-05-26       Impact factor: 38.585

8.  Visualizing Spatial and Stoichiometric Barriers to Bispecific T-Cell Engager Efficacy.

Authors:  Ran You; Jordan Artichoker; Arja Ray; Hugo Gonzalez Velozo; Dan A Rock; Kip P Conner; Matthew F Krummel
Journal:  Cancer Immunol Res       Date:  2022-06-03       Impact factor: 12.020

9.  Functional heterogeneity of cytotoxic T cells and tumor resistance to cytotoxic hits limit anti-tumor activity in vivo.

Authors:  Roxana Khazen; Marine Cazaux; Fabrice Lemaître; Beatrice Corre; Zacarias Garcia; Philippe Bousso
Journal:  EMBO J       Date:  2021-04-15       Impact factor: 14.012

10.  Active surveillance characterizes human intratumoral T cell exhaustion.

Authors:  Ran You; Jordan Artichoker; Adam Fries; Austin W Edwards; Alexis J Combes; Gabriella C Reeder; Bushra Samad; Matthew F Krummel
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.